Atherosclerotic plaque rupture is a significant cause
of acute
cardiovascular events such as heart attack and stroke, triggered by
the decomposition of fiber caps induced by cysteine cathepsin. However,
the accurate measurement of cathepsin B (CTB) activity in plaques
is challenging due to the low specificity and insufficient penetration
depth of available atherosclerosis-associated cathepsin fluorescent
probes, hampering reliable assessment of plaque vulnerability. To
address these limitations, we added both lipophilic alkyl chain and
hydrophilic CTB substrate to the hemicyanine scaffold to develop a
lipid-unlocked CTB responsive probe (L-CRP) that uses lipids and CTB
as two keys to unlock photoacoustic (PA) signals for measuring CTB
activity in lipophilic environments. Such properties allow L-CRP for
the reliable imaging of specific CTB activities in foam cells and
atherosclerotic plaques while keeping in silence toward CTB in lipid-deficient
environments, such as M1-type macrophages and LPS-induced inflammatory
lesions. Moreover, the activatable PA signals of L-CRP exhibit a deeper
tissue penetration ability (>1.0 cm) than current CTB probes based
on near-infrared fluorescent imaging (∼0.3 cm), suitable for
atherosclerosis imaging in living mice. In atherosclerotic mice, L-CRP
dynamically reports intraplaque CTB levels, which is well-correlated
with the plaque vulnerability characteristics such as fiber cap thickness,
macrophage recruitment, and necrotic core size, thus enabling risk
stratification of atherosclerotic mice complicated with pneumonia.
Moreover, L-CRP successfully identifies atherosclerotic plaques in
excised human artery tissues, promising for auxiliary diagnosis of
plaque vulnerability in clinical application.